GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Twist Bioscience
Twist Bioscience is a leader in synthetic DNA production. Its stock price is a bet on a revolution in biotechnology. The chart reflects the growing demand for its products from pharmaceutical companies and researchers to develop new drugs and therapies.
Share prices of companies in the market segment - Dna
Twist Bioscience is a leader in synthetic DNA production. Its primary segment is the sale of DNA for pharmaceutical and research applications. We classify it as part of the DNA sector, and the chart below reflects the dynamics of the entire biotech industry, where its products are a key consumable.
Broad Market Index - GURU.Markets
Twist Bioscience is a leader in synthetic biology, producing synthetic DNA for use in medicine, agriculture, and industrial applications. It is a component of the GURU.Markets index. The chart below shows the market. See how Twist shares compare to the biotech sector.
Change in the price of a company, segment, and market as a whole per day
TWST - Daily change in the company's share price Twist Bioscience
Shares of Twist Bioscience, a synthetic DNA company, exhibit high volatility, as measured by change_co. This reflects the stock's sensitivity to scientific breakthroughs and demand from the biotech industry. This metric is important for analyzing innovative sectors on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Dna
Twist Bioscience Corporation is a leader in DNA synthesis. This chart illustrates the high volatility of the biotech sector. Comparing it to TWST's performance helps us understand how its unique technology platform makes it more or less sensitive to overall industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Twist Bioscience is a leader in the production of synthetic DNA for biotech and pharmaceutical research. Its business serves as a barometer of global scientific activity. The chart below shows general market fluctuations, which can be used to assess how the market is responding to breakthrough technologies.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Twist Bioscience
Twist is a leader in DNA synthesis, producing genetic material for biotech companies and research labs. Its year-over-year growth is a barometer of R&D investment in the industry. The chart below tells the story of a "picks and shovels" seller in the biotech revolution.
Annual dynamics of market capitalization of the market segment - Dna
Twist Bioscience Corporation has revolutionized DNA synthesis, making it fast and affordable. Its platform is the foundation for many biotech research projects, from drug development to data storage. The graph shows how its technological leadership and rapid growth in this fundamental field are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Twist Bioscience, which produces synthetic DNA, is a gold mine for the biotech revolution. Demand for its products is determined by R&D budgets, not the state of the economy. The company's stock price is a long-term growth story, based on the fact that its "building blocks" are needed to create new drugs and materials.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Twist Bioscience
Twist Bioscience, a leader in DNA synthesis, produces "DNA on demand" for researchers. The monthly fluctuations on the chart reflect demand from biotech and pharmaceutical companies for its drug discovery products, as well as the growth of its DNA data storage business.
Monthly dynamics of market capitalization of the market segment - Dna
Twist Bioscience produces synthetic DNA on a large scale using semiconductor technology. Their DNA is used in medicine, agriculture, and data storage. They serve as a "printing house" for the life sciences industry. The graph below shows the overall dynamics of the biotechnology sector, where Twist serves as a key tool provider.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Twist Bioscience works in the field of synthetic biology, "printing" DNA for research and industrial purposes. It's a company of the future, and its stock reflects investors' faith in the biotech revolution. Its momentum is determined by the speed of adoption of its technology, not by current economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Twist Bioscience
The weekly performance of Twist Bioscience, a company that produces synthetic DNA, is a barometer of the biotech revolution. Its stock price responds to demand from pharmaceutical companies and research labs that use its products for drug development and diagnostics.
Weekly dynamics of market capitalization of the market segment - Dna
Synthetic biology is a sector where weekly dynamics reflect the pace of scientific innovation. Demand for synthetic DNA from the pharmaceutical and biotech industries is a common driver. The chart illustrates this backdrop, which allows one to appreciate Twist Bioscience's technological leadership.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Twist Bioscience produces synthetic DNA for use in medicine, industry, and agriculture. The company is at the forefront of the biotech revolution. The chart will show whether Twist shares are living their own life, responding to scientific breakthroughs, or whether their high valuation makes them sensitive to overall market volatility.
Market capitalization of the company, segment and market as a whole
TWST - Market capitalization of the company Twist Bioscience
Twist Bioscience's market capitalization chart tells the story of a revolution in synthetic DNA production. The company learned to "print" DNA on silicon chips, making research cheaper and faster. Its volatile dynamics reflect both its enormous potential in medicine and data storage, as well as the long and costly path to profitability.
TWST - Share of the company's market capitalization Twist Bioscience within the market segment - Dna
Twist Bioscience is a leader in the production of synthetic DNA for a variety of applications, from drug discovery to data storage. Its dominant market share reflects the superiority of its platform. The chart shows the company's importance in providing the fundamental building blocks for the biotech revolution.
Market capitalization of the market segment - Dna
Twist Bioscience is a leader in the production of synthetic DNA for biotech and pharmaceutical research. The chart below shows the market capitalization of this revolutionary sector. Its growth reflects the growing role of genetic engineering and synthetic biology in the creation of new drugs, chemicals, and materials.
Market capitalization of all companies included in a broad market index - GURU.Markets
Twist Bioscience produces synthetic DNA for use in medicine, agriculture, and data storage. Its market capitalization reflects its leadership in this fundamental technology. The chart below shows the economic weight of the synthetic biology sector.
Book value capitalization of the company, segment and market as a whole
TWST - Book value capitalization of the company Twist Bioscience
Twist Bioscience's balance sheet is its unique "silicon" platform for DNA synthesis, laboratories, and patent portfolio. This is real, science-intensive capital that produces the "code of life" for biotechnology and data storage. How has this revolutionary asset grown? The chart below shows its explosive yet volatile performance.
TWST - Share of the company's book capitalization Twist Bioscience within the market segment - Dna
Twist Bioscience produces synthetic DNA in its highly automated "gene factories." The chart shows the share of these unique and cutting-edge production assets in the biotech sector, reflecting the physical foundation upon which modern synthetic biology is built.
Market segment balance sheet capitalization - Dna
DNA synthesis, as the BCap_Seg graph for biotech shows, is a high-tech process, but not as capital-intensive as heavy industry. Twist Bioscience is a leader in this niche. Its "factories" are silicon chips, making its production more scalable and less capital-intensive than traditional methods.
Book value of all companies included in the broad market index - GURU.Markets
Twist Bioscience's book value represents its highly automated laboratories and DNA synthesis facilities. It reflects the physical capital invested in its unique technology for "writing" genetic code onto silicon chips, creating the material foundation for a revolution in biotechnology and medicine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Twist Bioscience
Twist Bioscience produces synthetic DNA for biotech research. The book value of its plants is disproportionate to the value of its technology platform. The MvsBCap chart shows the enormous premium investors are paying for leadership in this breakthrough field. This trend reflects the belief that DNA "writing" will usher in a new era of medicine.
Market to book capitalization ratio in a market segment - Dna
Twist Bioscience produces synthetic DNA for biotechnology clients. Its value lies in its unique DNA "writing" platform. The chart shows the significant premium the market pays for its breakthrough technology and leadership in synthetic biology, not the cost of its lab equipment.
Market to book capitalization ratio for the market as a whole
Twist Bioscience has revolutionized DNA synthesis, making it fast and affordable. It's a platform company whose technologies are used in medicine, agriculture, and data storage. Its market value reflects the enormous potential applications of its developments. The chart shows how investors value the business at the heart of the biotech revolution.
Debts of the company, segment and market as a whole
TWST - Company debts Twist Bioscience
Twist Bioscience, a DNA synthesis specialist, is using the capital raised to scale its production and fund research. Creating "DNA on demand" for pharmaceuticals and biotech is a capital-intensive undertaking. This chart shows how the company is investing in technologies that could revolutionize many industries, from medicine to data storage.
Market segment debts - Dna
Twist Bioscience has revolutionized DNA synthesis, making it fast and affordable. This technology has applications in medicine, agriculture, and data storage. For a company at the forefront of biotechnology, investments in R&D and production scaling are enormous. The chart shows how Twist funds its exponential growth and scientific breakthroughs.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Twist Bioscience
Twist Bioscience produces synthetic DNA for biotechnology clients. The chart shows how the company finances its high-tech business. For a leader in an emerging industry requiring significant investment in R&D and production capacity, its capital structure reflects a balance between aggressive growth and financial prudence.
Market segment debt to market segment book capitalization - Dna
Twist Bioscience produces synthetic DNA, which has applications in medicine and biotechnology. This metric, which is relevant for a science-intensive industry, shows how much capital is raised to fund breakthrough research. It helps understand whether the company's debt is an investment in future growth or a consequence of high current expenses.
Debt to book value of all companies in the market
Twist Bioscience operates at the forefront of biotechnology. This chart reflects the overall risk appetite in the economy. For a company burning capital for future discoveries, it helps understand how its risky funding model compares to the overall market conditions and investors' willingness to wait.
P/E of the company, segment and market as a whole
P/E - Twist Bioscience
The chart for Twist Bioscience, a company that produces synthetic DNA, shows how investors view it as a key player in the biotech revolution. The high values reflect a belief in the exponential growth of demand for its products from pharmaceutical and research organizations worldwide.
P/E of the market segment - Dna
This chart shows the average P/E for the biotech sector, where Twist Bioscience offers a unique technology. The high average valuation reflects a belief in genetic engineering. This metric helps understand how much the market is willing to pay a premium for Twist's DNA synthesis platform compared to other biotech companies.
P/E of the market as a whole
Twist Bioscience produces synthetic DNA for customers in healthcare, industrial, and agricultural sectors. The company provides a fundamental tool for the biotech revolution. This market sentiment chart allows you to compare Twist's lofty valuation with the market and understand whether it is a justified bet on the future of synthetic biology.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Twist Bioscience
Twist Bioscience produces synthetic DNA for clients in the biotech and pharmaceutical industries. The chart shows high investor expectations for future revenue, which depend on the growth of the synthetic biology market and the company's ability to scale its production. This is a bet on a revolution in biotechnology and genetic engineering.
%20P%2FE%20Twist%20Bioscience&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Twist-Bioscience&v=1772513497274 "Chart of the company's future (projected) P/E Twist Bioscience")
Future (projected) P/E of the market segment - Dna
Twist Bioscience produces synthetic DNA on its silicon platform, serving clients in biotech, pharmaceuticals, and academia. This chart shows expectations for future profitability in the sector. It helps understand how much investors believe Twist's technology will become an industry standard and drive revenue growth.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Dna&v=1772513497276 "Future (projected) P/E graph of the market segment - Dna")
Future (projected) P/E of the market as a whole
Twist Bioscience produces synthetic DNA for clients in the healthcare and biotechnology sectors. The company is a key supplier for genetic engineering and drug development. This overall risk appetite chart helps understand how willing investors are to invest in breakthrough technologies shaping the future of medicine.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513497286 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Twist Bioscience
Twist Bioscience revolutionized biotechnology by developing a platform for large-scale synthetic DNA production. The company generates revenue by selling genes, DNA libraries, and other products to researchers. This chart shows how demand for genetic engineering and drug discovery tools is fueling the company's growth.
Profit of companies in the market segment - Dna
Twist Bioscience has revolutionized DNA synthesis by creating a platform for "printing" genetic code on an industrial scale for applications in medicine, agriculture, and data storage. This chart illustrates the broader picture in the biotech sector, where breakthrough platform technologies like Twist's can accelerate research and development across the industry.
Overall market profit
Twist Bioscience synthesizes DNA for clients in healthcare, manufacturing, and agriculture. The company operates at the forefront of the biotech revolution. Its growth is driven by the pace of innovation and the adoption of genetic engineering, not by current economic cycles. The dynamics in this chart have little bearing on long-term demand for basic biotech tools.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Twist Bioscience
Twist Bioscience produces synthetic DNA for customers in the healthcare and biotechnology sectors. Future profits depend on demand for tools for genetic engineering, drug discovery, and DNA-based data storage. This chart shows analysts' assessments of the growth prospects of this innovative company at the forefront of the biotech revolution.
%20profit%20of%20the%20company%20Twist%20Bioscience&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Twist-Bioscience&v=1772513497402 "Graph of future (projected) profit of the company Twist Bioscience")
Future (predicted) profit of companies in the market segment - Dna
Twist Bioscience has revolutionized DNA synthesis, offering high-quality synthetic genetic material to medical and biotechnology researchers. The company's growth is fueled by innovations in genetic engineering. This chart shows overall revenue projections for the biotech sector, allowing you to assess how Twist's technologies are driving industry-wide growth.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Dna&v=1772513497430 "Graph of future (predicted) profits of companies in a market segment - Dna")
Future (predicted) profit of the market as a whole
Twist Bioscience produces synthetic DNA for clients in the biotech and pharmaceutical industries. Demand for its products depends on the level of research and development (R&D) spending in these industries. This economic outlook is important because it influences R&D budgets and investor willingness to fund scientific research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513497457 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Twist Bioscience
Twist Bioscience produces synthetic DNA for clients in the biotech and pharmaceutical industries. Its revenue growth reflects growing demand for genetic engineering tools. This chart shows how highly investors value its technology platform and its role in the biotech revolution. The multiple reflects high expectations.
P/S market segment - Dna
Twist Bioscience is a leader in synthetic biology. The company produces synthetic DNA on an industrial scale for clients developing drugs, chemicals, and agricultural products. Their platform accelerates innovation in biotechnology. This chart reflects the average revenue estimate for the sector, which helps evaluate Twist's breakthrough technology.
P/S of the market as a whole
Twist Bioscience produces synthetic DNA for clients in the biotech and pharmaceutical industries, accelerating scientific research. The company is a key supplier for genetic engineering. This chart shows the significant premium investors are willing to pay for the revenue of the company at the heart of the biotech revolution, compared to the market average.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Twist Bioscience
Twist Bioscience produces synthetic DNA for customers in healthcare, industrial chemistry, and agriculture. For a company creating foundational tools for the biotech revolution, its revenue valuation is critical. It reflects investors' faith in the exponential growth of demand for synthetic biology and Twist's ability to scale its production.
%20P%2FS%20Twist%20Bioscience&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Twist-Bioscience&v=1772513497562 "The graph of the company's future (projected) P/S Twist Bioscience")
Future (projected) P/S of the market segment - Dna
Twist Bioscience produces synthetic DNA for customers in healthcare, industrial chemistry, and agriculture. This chart reflects how investors view the company's future revenues relative to the biotech sector. It demonstrates the market's confidence in its silicon-based platform, which enables DNA production at scale and at a low cost, opening up new research opportunities.
%20P%2FS%20market%20segment%20graph%20-%20Dna&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Dna&v=1772513497590 "Future (projected) P/S market segment graph - Dna")
Future (projected) P/S of the market as a whole
Twist Bioscience synthesizes DNA for use in medicine, industry, and agriculture. The company is at the forefront of the biotech revolution. Revenue growth projections, shown in this chart, will increasingly depend on innovations like those offered by Twist.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513497617 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Twist Bioscience
This chart shows the revenue of Twist Bioscience, a company that produces synthetic DNA for clients in the healthcare and biotechnology sectors. Revenue is generated from the sale of genes, oligonucleotide pools, and other research products. The growth in this indicator indicates growing demand for tools for genetic engineering and drug development.
Sales of companies in the market segment - Dna
Twist Bioscience has revolutionized DNA synthesis, making it fast and affordable. This chart shows how the company's revenue is split between sales of synthetic DNA for research, next-generation sequencing (NGS) products, and biopharmaceutical solutions. This reflects the broad application of its technology in science and medicine.
Overall market sales
Twist Bioscience produces synthetic DNA for clients in the healthcare and biotechnology sectors. The company's growth is driven by the revolution in genetic engineering and personalized medicine. This graph illustrates how the disruptive, science-intensive industries shaping the future of medicine are developing independently of the traditional economic cycles depicted on it.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Twist Bioscience
Twist Bioscience produces synthetic DNA for customers in healthcare, industrial chemistry, and agriculture. The company's growth depends on demand for genetic engineering tools and the development of biotechnology. This chart shows analysts' expectations for DNA sales, reflecting their views on the pace of growth and innovation in the vast field of synthetic biology.
%20sales%20of%20the%20company%20Twist%20Bioscience&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Twist-Bioscience&v=1772513497832 "Schedule of future (projected) sales of the company Twist Bioscience")
Future (projected) sales of companies in the market segment - Dna
Twist Bioscience produces synthetic DNA for clients in the biotech and pharmaceutical industries. This chart shows sales forecasts for the life sciences sector. Is increased investment in research and development expected to drive demand for DNA synthesis? This reflects the overall scientific and commercial potential of the industry.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Dna&v=1772513497846 "Schedule of future (projected) sales of companies in the market segment - Dna")
Future (projected) sales of the market as a whole
Twist Bioscience produces synthetic DNA for clients in the healthcare and biotechnology sectors. Demand for its products depends on the level of funding for biotech research and development (R&D). This dynamic has an indirect impact: during periods of economic growth, investment in science increases, but the primary driver is the pace of scientific progress and innovation.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513497857 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Twist Bioscience
Twist Bioscience produces synthetic DNA on its silicon platform, serving medical and biotechnology researchers. This chart shows how effectively the company is scaling its unique technology. Profitability depends on the decreasing cost of DNA synthesis, which opens new markets, and on growing demand for its genetic engineering and data storage products.
Market segment marginality - Dna
Twist Bioscience Corporation produces synthetic DNA for clients in the biotech and pharmaceutical industries. Its platform enables DNA production at scale and at a lower cost than traditional methods. This metric reflects the financial health of a rapidly growing company whose profitability depends on scaling production and demand for its unique technology.
Market marginality as a whole
Twist Bioscience produces synthetic DNA for use in medicine, agriculture, and industry. Demand for its products depends on biotech research activity. This overall profitability chart reflects the investment climate. During growth periods, investors and companies are more willing to fund R&D, which expands Twist's customer base.
Employees in the company, segment and market as a whole
Number of employees in the company Twist Bioscience
Twist Bioscience produces synthetic DNA for clients in the biotech and pharmaceutical industries. Its business requires both scientists and automation specialists. This chart shows how the company is scaling its manufacturing and research teams to meet the growing demand for DNA-as-a-service and to develop new products.
Share of the company's employees Twist Bioscience within the market segment - Dna
Twist Bioscience revolutionized DNA synthesis by creating a platform for industrial-scale production of synthetic genes. Its business operates at the intersection of biotechnology and IT, requiring a team of biologists, chemists, and programmers. This graph shows the company's labor market share, an indicator of its leadership and scale in the emerging synthetic biology industry.
Number of employees in the market segment - Dna
Twist Bioscience produces synthetic DNA for clients in healthcare, industry, and agriculture. This chart shows employment in the genetic engineering sector. The exponential growth of scientists in this field speaks to a revolution in biotechnology. Twist's platform accelerates research, making the company a key player in this field.
Number of employees in the market as a whole
Twist Bioscience produces synthetic DNA for use in medicine, agriculture, and industry. Its growing workforce of scientists and technicians reflects the revolution in biotechnology. Compared to the overall employment shown in this chart, Twist's hiring reflects the growing demand for tools for genetic engineering and drug discovery.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Twist Bioscience (TWST)
Twist Bioscience produces synthetic DNA for biotech research. This chart shows how the market values their unique platform. They've automated a previously labor-intensive process. Their high market capitalization per employee reflects the value of their technology, which has become a fundamental tool for the entire industry.
%20of%20the%20company%20Twist%20Bioscience%20(TWST)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Twist-Bioscience-TWST&v=1772513498009 "Chart of market capitalization per employee (in thousands of dollars) of the company Twist Bioscience (TWST)")
Market capitalization per employee (in thousands of dollars) in the market segment - Dna
Twist Bioscience (TWST) is a leader in synthetic DNA production. They use their silicon platform to "print" DNA at scale for biotech, pharmaceuticals, and data storage. This chart shows the industry average cost per employee. It helps estimate the premium the market pays for their unique technology platform per scientist.
%20by%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Dna&v=1772513498020 "Market capitalization per employee (in thousands of dollars) by market segment - Dna")
Market capitalization per employee (in thousands of dollars) for the overall market
Twist Bioscience produces synthetic DNA for use in medicine and biotechnology. The company has automated this process on its silicon platform. The graph shows a huge cost per employee, as the technology enables DNA production on an unprecedented scale with minimal human intervention, creating enormous added value.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513498023 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Twist Bioscience (TWST)
Twist Bioscience is a leader in DNA "writing." The company produces synthetic DNA on its silicon platform for biotech and R&D. This high-tech production facility is a must-have. This graph shows how effectively the company scales its unique technology. Revenue per employee increases as the platform enables greater DNA production without increasing headcount.
%20Chart%20Twist%20Bioscience%20(TWST)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Twist-Bioscience-TWST&v=1772513498043 "Company Profit Per Employee (in thousands of dollars) Chart Twist Bioscience (TWST)")
Profit per employee (in thousands of dollars) in the market segment - Dna
Twist Bioscience (TWST) is a synthetic DNA "factory" (for biotech). This chart shows the benchmark for "DNA" (Life Science Tools). The average profit per employee here is high (or negative if it's R&D). It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from "blades" (custom DNA synthesis).
%20in%20the%20market%20segment%20-%20Dna&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Dna&v=1772513498066 "Chart of profit per employee (in thousands of dollars) in the market segment - Dna")
Profit per employee (in thousands of dollars) for the market as a whole
Twist Bioscience is a company that produces synthetic DNA on its silicon platform for biotech and R&D. It's an "R&D-as-a-Service" company. This graph shows how scalable their unique DNA printing technology is. While the company is investing in growth, it may be negative, but it shows how much the company spends on DNA production per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513498068 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Twist Bioscience (TWST)
Twist Bioscience produces synthetic DNA for biotechnology clients. This chart shows how their unique DNA synthesis platform on a silicon chip scales. Growing revenue per employee demonstrates the company's ability to produce increasing amounts of DNA on demand without a corresponding increase in staff, a key advantage.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Twist-Bioscience-TWST&v=1772513498072 "Sales chart per company employee Twist Bioscience (TWST)")
Sales per employee in the market segment - Dna
Twist Bioscience produces synthetic DNA for biotechnology, pharmaceuticals, and data storage. It's a cutting-edge facility at the intersection of biology and IT. This graph shows the average output for the sector. For TWST, this is an indicator of how scalable and productive their highly automated DNA printing platform is per scientist/engineer.
Sales per employee for the market as a whole
Twist Bioscience produces custom synthetic DNA for biotech and pharmaceutical companies. They are a "DNA factory." Their business model is based on a technology platform that enables DNA production at scale and at a lower cost. This graph demonstrates how scalable and efficient this platform is.
Short shares by company, segment and market as a whole
Shares shorted by company Twist Bioscience (TWST)
Twist Bioscience (TWST) produces synthetic DNA on its silicon platform for use in biotechnology, medicine, and agriculture. This chart shows the volume of bearish bets. The shorts may be related to the company's high valuation, which is still unprofitable, and concerns that competition or technological challenges will prevent it from achieving scale and profitability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Twist-Bioscience-TWST&v=1772513498091 "Short Shares Chart for the Company Twist Bioscience (TWST)")
Shares shorted by market segment - Dna
Twist Bioscience (TWST) produces synthetic DNA on a large scale using a silicon platform for pharmaceuticals and biotech. This chart shows the total short position in the "life science tools" sector. It reflects investor concerns about slowing funding in biotech, which is reducing demand for DNA synthesis.
Shares shorted by the overall market
Twist (TWST) is a biotech company producing synthetic DNA for R&D. Their clients are biotech companies. This Short_All chart shows risk aversion. This pessimism is drying up venture capital funding for biotech companies (TWST's clients). Ultimately, they have no money left for R&D, which is killing Twist's main source of revenue.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Twist Bioscience (TWST)
Twist Bioscience (TWST) is a leader in synthetic biology. They produce synthetic DNA on a large scale for biotech research, diagnostics, and data storage. It's a fast-growing but expensive field. This chart measures hype. It shows "overbought" (above 70) amid the hype around genetic engineering, or "oversold" (below 30) due to concerns about high cash burn.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Twist-Bioscience-TWST&v=1772513498118 "RSI 14 indicator chart for the company's stock Twist Bioscience (TWST)")
RSI 14 Market Segment - Dna
Twist Bioscience (TWST) is a "DNA factory." They print (synthesize) DNA on an industrial scale for biotech (R&D) and data storage. The RSI_14_Seg for "Dna" (genomics) shows the "temperature" in this cutting-edge sector. The chart helps us understand: is TWST's growth driven by their technology or is the entire sector overheated?
RSI 14 for the overall market
Twist Bioscience (TWST) synthesizes DNA for biotech companies. This chart is the pulse of its clients. In a euphoric rush, biotech companies (its clients) are generously funded and buying up TWST's R&D "consumables." In a panic, R&D funding dries up, and research budgets (TWST's lifeblood) are the first to be cut.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TWST (Twist Bioscience)
Twist Bioscience (TWST) produces synthetic DNA at scale using its silicon platform. This is a key tool for biotechnology, drug development, and data storage. This chart shows the average analyst forecast. Their price targets are based on growing demand for synthetic DNA and the long-term potential of DNA data storage.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TWST-Twist-Bioscience&v=1772513498147 "A chart showing analyst consensus forecasts for the expected stock price. TWST (Twist Bioscience)")
The difference between the consensus estimate and the actual stock price TWST (Twist Bioscience)
Twist Bioscience is a leader in synthetic biology. They use a silicon platform to print DNA on an industrial scale, providing synthetic genes to researchers in pharmaceuticals, biotech, and industrial applications. This chart shows how analysts rate them as a key supplier of consumables for the R&D boom in biotech.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TWST-Twist-Bioscience&v=1772513498170 "A chart showing the difference between the consensus forecast and the actual stock price. TWST (Twist Bioscience)")
Analyst consensus forecast for stock prices by market segment - Dna
Twist Bioscience is a pioneer in the field of synthetic biology. The company has developed technology for producing synthetic DNA on silicon chips at industrial scale. This chart shows analysts' overall expectations for the DNA technology sector. It reflects whether experts believe demand for synthetic DNA for R&D and data storage will grow.
Analysts' consensus forecast for the overall market share price
Twist Bioscience is a leader in DNA synthesis. They print DNA on silicon chips, serving biotechnology (R&D) and developing DNA data storage. This is a breakthrough technology. This chart shows the overall market sentiment. For Twist, whose business is consumables for science, it's important to understand how these expectations (risk appetite) influence biotech R&D budgets. (343)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Twist Bioscience
Twist (TWST) is a synthetic DNA manufacturing company. Using their silicon platform, they print DNA on an industrial scale for biotech and pharmaceutical companies that need it for R&D. This chart is the biotech industry's pick and shovel. It measures the R&D budgets of the entire industry and their transition from handcrafted to factory-scale DNA production.
AKIMA Market Segment Index - Dna
Twist (TWST) is a leader in synthetic biology; the company uses its silicon platform to print (produce) synthetic DNA at industrial scale for R&D (pharma, biotech). This summary metric evaluates R&D. The graph shows the segment average. This benchmark: how does this revolutionary platform (DNA printing) differentiate Twist from the average pharma company?
The AKIM Index for the overall market
Twist Bioscience is a leader in synthetic biology. The company produces synthetic DNA on silicon chips for medicine, agriculture, and data storage. This chart, which reflects the market average, is a backdrop. It helps assess how this innovative platform, which powers R&D for other companies, compares to overall macroeconomic trends.
